{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:37:04Z","timestamp":1781613424815,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00059-018-4709-z","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T12:29:09Z","timestamp":1526473749000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Peripartum cardiomyopathy","Peripartale Kardiomyopathie"],"prefix":"10.1007","volume":"43","author":[{"given":"T.","family":"Koenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hilfiker-Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"4709_CR1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/AOG.0b013e3181fdfb11","volume":"116","author":"CJ Berg","year":"2010","unstructured":"Berg CJ, Callaghan WM, Syverson C et al (2010) Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 116:1302\u20131309","journal-title":"Obstet Gynecol"},{"key":"4709_CR2","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(16)31470-2","volume":"388","author":"GBDMM Collaborators","year":"2016","unstructured":"Collaborators GBDMM (2016) Global, regional, and national levels of maternal mortality, 1990\u20132015: a\u00a0systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1775\u20131812","journal-title":"Lancet"},{"key":"4709_CR3","doi-asserted-by":"publisher","first-page":"e000712","DOI":"10.1161\/JAHA.113.000712","volume":"3","author":"M Nanna","year":"2014","unstructured":"Nanna M, Stergiopoulos K (2014) Pregnancy complicated by valvular heart disease: an update. J\u00a0Am Heart Assoc 3:e712","journal-title":"J Am Heart Assoc"},{"key":"4709_CR4","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr272","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart\u00a0J 32:3147\u20133197","journal-title":"Eur Heart J"},{"key":"4709_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cvr\/cvu012","volume":"101","author":"K Sliwa","year":"2014","unstructured":"Sliwa K, Bohm M (2014) Incidence and prevalence of pregnancy-related heart disease. Cardiovasc Res 101:554\u2013560","journal-title":"Cardiovasc Res"},{"key":"4709_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","volume":"11","author":"D Hilfiker-Kleiner","year":"2014","unstructured":"Hilfiker-Kleiner D, Sliwa K (2014) Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 11:364\u2013370","journal-title":"Nat Rev Cardiol"},{"key":"4709_CR7","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ejhf.586","volume":"18","author":"J Bauersachs","year":"2016","unstructured":"Bauersachs J, Arrigo M, Hilfiker-Kleiner D et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 18:1096\u20131105","journal-title":"Eur J Heart Fail"},{"key":"4709_CR8","doi-asserted-by":"publisher","first-page":"366-013-0366-03","DOI":"10.1007\/s00395-013-0366-9","volume":"108","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Podewski E, Libhaber E et al (2013) Phenotyping and outcome on contemporary management in a\u00a0German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 108:366-013-0366-0369","journal-title":"Basic Res Cardiol"},{"key":"4709_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a\u00a0position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767\u2013778","journal-title":"Eur J Heart Fail"},{"key":"4709_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/eurheartj\/ehv009","volume":"36","author":"D Hilfiker-Kleiner","year":"2015","unstructured":"Hilfiker-Kleiner D, Haghikia A, Nonhoff J et al (2015) Peripartum cardiomyopathy: current management and future perspectives. Eur Heart\u00a0J 36:1090\u20131097","journal-title":"Eur Heart J"},{"key":"4709_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","volume":"374","author":"JS Ware","year":"2016","unstructured":"Ware JS, Li J, Mazaika E et\u00a0al (2016) Shared genetic predisposition in peripartum and dilated cardiomyopathies. N\u00a0Engl J Med 374:233\u2013241","journal-title":"N Engl J Med"},{"key":"4709_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","volume":"283","author":"GD Pearson","year":"2000","unstructured":"Pearson GD, Veille JC, Rahimtoola S et\u00a0al (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283:1183\u20131188","journal-title":"JAMA"},{"key":"4709_CR13","doi-asserted-by":"publisher","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS et al (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a\u00a0nationwide population-based study. J\u00a0Am Heart Assoc 3:e1056","journal-title":"J Am Heart Assoc"},{"key":"4709_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM Mcnamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R et al (2015) Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J\u00a0Am Coll Cardiol 66:905\u2013914","journal-title":"J Am Coll Cardiol"},{"key":"4709_CR15","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","volume":"38","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a\u00a0multicentre randomized study. Eur Heart\u00a0J 38:2671\u20132679","journal-title":"Eur Heart J"},{"key":"4709_CR16","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","volume":"62","author":"N Bello","year":"2013","unstructured":"Bello N, Rendon IS, Arany Z (2013) The relationship between pre-eclampsia and peripartum cardiomyopathy: a\u00a0systematic review and meta-analysis. J\u00a0Am Coll Cardiol 62:1715\u20131723","journal-title":"J Am Coll Cardiol"},{"key":"4709_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ejhf.780","volume":"19","author":"K Sliwa","year":"2017","unstructured":"Sliwa K, Mebazaa A, Hilfiker-Kleiner D et al (2017) Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail 19:1131\u20131141","journal-title":"Eur J Heart Fail"},{"key":"4709_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","volume":"2","author":"OC Irizarry","year":"2017","unstructured":"Irizarry OC, Levine LD, Lewey J et al (2017) Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiol 2:1256\u20131260","journal-title":"JAMA Cardiol."},{"key":"4709_CR19","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jamacardio.2017.3605","volume":"2","author":"J Bauersachs","year":"2017","unstructured":"Bauersachs J (2017) Poor outcomes in poor patients? Peripartum cardiomyopathy-not just black and white. JAMA Cardiol 2:1261\u20131262","journal-title":"JAMA Cardiol."},{"key":"4709_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ejhf.808","volume":"19","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Masuko D et al (2017) Outcome of subsequent pregnancies in patients with a\u00a0history of peripartum cardiomyopathy. Eur J Heart Fail 19:1723\u20131728","journal-title":"Eur J Heart Fail"},{"key":"4709_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","volume":"368","author":"K Sliwa","year":"2006","unstructured":"Sliwa K, Fett J, Elkayam U (2006) Peripartum cardiomyopathy. Lancet 368:687\u2013693","journal-title":"Lancet"},{"key":"4709_CR22","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1253\/circj.CJ-16-1193","volume":"81","author":"A Mebazaa","year":"2017","unstructured":"Mebazaa A, Seronde MF, Gayat E et al (2017) Imbalanced angiogenesis in peripartum cardiomyopathy-diagnostic value of placenta growth factor. Circ\u00a0J 81:1654\u20131661","journal-title":"Circ J"},{"key":"4709_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS, Rana S, Shahul S et\u00a0al (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333\u2013338","journal-title":"Nature"},{"key":"4709_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E et al (2007) A cathepsin D\u2011cleaved 16\u202fkDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589\u2013600","journal-title":"Cell"},{"key":"4709_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke-Hoch M et al (2013) MicroRNA-146a is a\u00a0therapeutic target and biomarker for peripartum cardiomyopathy. J\u00a0Clin Invest 123:2143\u20132154","journal-title":"J Clin Invest"},{"key":"4709_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C et\u00a0al (2004) Circulating angiogenic factors and the risk of preeclampsia. N\u00a0Engl J Med 350:672\u2013683","journal-title":"N Engl J Med"},{"key":"4709_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12265-017-9764-y","volume":"10","author":"YZJ Lee","year":"2017","unstructured":"Lee YZJ, Judge DP (2017) The role of genetics in peripartum cardiomyopathy. J\u00a0Cardiovasc Transl Res 10:437\u2013445","journal-title":"J Cardiovasc Transl Res"},{"key":"4709_CR28","doi-asserted-by":"publisher","first-page":"e004620","DOI":"10.1161\/CIRCHEARTFAILURE.117.004620","volume":"11","author":"J Bauersachs","year":"2018","unstructured":"Bauersachs J, Koenig T (2018) Devil in disguise: hints and pitfalls in diagnosis of peripartum cardiomyopathy. Circ Heart Fail 11:e4620","journal-title":"Circ Heart Fail"},{"key":"4709_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et\u00a0al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart\u00a0J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"4709_CR30","first-page":"349","volume":"38","author":"B Stapel","year":"2017","unstructured":"Stapel B, Kohlhaas M, Ricke-Hoch M et al (2017) Low STAT3 expression sensitizes to toxic effects of beta-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart\u00a0J 38:349\u2013361","journal-title":"Eur Heart J"},{"key":"4709_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.accpm.2016.02.009","volume":"36","author":"I Labbene","year":"2017","unstructured":"Labbene I, Arrigo M, Tavares M et\u00a0al (2017) Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy. Anaesth Crit Care Pain Med 36:39\u201342","journal-title":"Anaesth Crit Care Pain Med"},{"key":"4709_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2016.04.143","volume":"216","author":"A Haghikia","year":"2016","unstructured":"Haghikia A, Tongers J, Berliner D et\u00a0al (2016) Early ivabradine treatment in patients with acute peripartum cardiomyopathy: subanalysis of the German PPCM registry. Int J Cardiol 216:165\u2013167","journal-title":"Int J Cardiol"},{"key":"4709_CR33","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","volume":"121","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Blauwet L, Tibazarwa K et al (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a\u00a0proof-of-concept pilot study. Circulation 121:1465\u20131473","journal-title":"Circulation"},{"key":"4709_CR34","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1093\/eurheartj\/ehx428","volume":"38","author":"M Arrigo","year":"2017","unstructured":"Arrigo M, Blet A, Mebazaa A (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD. Eur Heart\u00a0J 38:2680\u20132682","journal-title":"Eur Heart J"},{"issue":"1","key":"4709_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15420\/cfr.2018:2:2","volume":"4","author":"T Koenig","year":"2018","unstructured":"Koenig T, Bauersachs J, Hilfiker-Kleiner D (2018) Bromocriptine for the treatment of peripartum cardiomyopathy. Card Fail Rev 4(1):46\u201349. \n                    https:\/\/doi.org\/10.15420\/cfr.2018:2:2","journal-title":"Card Fail Rev"},{"key":"4709_CR36","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ejhf.188","volume":"16","author":"D Duncker","year":"2014","unstructured":"Duncker D, Haghikia A, Konig T et al (2014) Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator. Eur J Heart Fail 16:1331\u20131336","journal-title":"Eur J Heart Fail"},{"key":"4709_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00392-017-1090-5","volume":"106","author":"D Duncker","year":"2017","unstructured":"Duncker D, Westenfeld R, Konrad T et al (2017) Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a\u00a0German multi-centre analysis. Clin Res Cardiol 106:582\u2013589","journal-title":"Clin Res Cardiol"},{"key":"4709_CR38","first-page":"139","volume":"2","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, Rontgen P, Vogel-Claussen J et al (2015) Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a\u00a0cardiovascular magnetic resonance study. Eur J Heart Fail 2:139\u2013149","journal-title":"Eur J Heart Fail"},{"key":"4709_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jacc.2011.03.047","volume":"58","author":"U Elkayam","year":"2011","unstructured":"Elkayam U (2011) Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J\u00a0Am Coll Cardiol 58:659\u2013670","journal-title":"J Am Coll Cardiol"},{"key":"4709_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1178","author":"K Sliwa","year":"2018","unstructured":"Sliwa K, Petrie MC, Hilfiker-Kleiner D et al (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. \n                    https:\/\/doi.org\/10.1002\/ejhf.1178","journal-title":"Eur J Heart Fail"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-018-4709-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-018-4709-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-018-4709-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T01:34:34Z","timestamp":1557970474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-018-4709-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4709"],"URL":"https:\/\/doi.org\/10.1007\/s00059-018-4709-z","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"16 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"T.\u00a0Koenig and D.\u00a0Hilfiker-Kleiner declare that they have no competing interests. J.\u00a0Bauersachs received honoraria for lectures and\/or consulting from Novartis, Pfizer, Vifor, Bayer, Servier, Orion, CVRx, Abiomed, Abbott\/SJM\/Thoratec, Medtronic\/Heartware, and research support from Zoll, CVRx, Bayer, Vifor, Abiomed, Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}